Efficacy and safety of Ginkgo biloba extract as an “add-on” treatment to metformin for patients with metabolic syndrome: a pilot clinical study
Open Access
- 1 July 2018
- journal article
- research article
- Published by Taylor & Francis in Therapeutics and Clinical Risk Management
- Vol. ume 14, 1219-1226
Abstract
Background and aim: Ginkgo biloba (GKB) extract has shown to be beneficial in experimental models of metabolic and inflammatory disorders such as diabetes and metabolic syndrome (MTS). The objective of this pilot clinical study was to evaluate the effects of GKB extract as an “add-on” treatment with metformin (Met) in MTS patients. Patients and methods: We performed a randomized, placebo-controlled, double-blinded clinical study in subjects with MTS. Forty patients completed the 90-day clinical trial and were randomly allocated to administer either GKB extract (120 mg capsule/day) or placebo (120 mg starch/day) as an add-on treatment with their currently used doses of Met for 90 days. During the study, body mass index (BMI), waist circumference (WC), serum leptin, glycated hemoglobin (HbA1c), fasting serum glucose (FSG), insulin, insulin resistance (IR), visceral adiposity index (VAI), lipid profile, and the inflammatory markers high sensitive C-reactive protein (hsCRP), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) were evaluated. Results: GKB extract significantly decreases HbA1c, FSG and insulin levels, IR, BMI, WC, VAI, serum leptin, and the inflammatory markers compared to baseline values. Simultaneously, GKB did not negatively affect the functions of the liver, kidney, and hematopoietic system. Conclusion: The use of GKB extract as an adjuvant with Met was effective in improving the outcome of patients with MTS.Keywords
This publication has 34 references indexed in Scilit:
- Assessment of a pharmacokinetic and pharmacodynamic interaction between simvastatin andGinkgo bilobaextracts in healthy subjectsXenobiotica, 2013
- Antihyperglycemic Effect ofGinkgo bilobaExtract in Streptozotocin-Induced Diabetes in RatsBioMed Research International, 2012
- Ginkgo biloba Extract and Bilberry Anthocyanins Improve Visual Function in Patients with Normal Tension GlaucomaJournal of Medicinal Food, 2012
- Protective Role of Ginkgo biloba Against Hepatotoxicity and Nephrotoxicity in Uranium-Treated MiceJournal of Medicinal Food, 2010
- Visceral Adiposity IndexDiabetes Care, 2010
- Harmonizing the Metabolic SyndromeCirculation, 2009
- Recovery of Islet β-Cell Function in Streptozotocin- Induced Diabetic MiceDiabetes, 2006
- The effect of the ingestion of Ginkgo biloba extract (EGb 761) on the pharmacokinetics of metformin in non-diabetic and type 2 diabetic subjects—A double blind placebo-controlled, crossover studyClinical Nutrition, 2006
- Biflavones of Ginkgo biloba Stimulate Lipolysis in 3T3-L1 AdipocytesPlanta Medica, 2002
- The Effect of 3‐Month Ingestion of Ginkgo biloba Extract (EGb 761) on Pancreatic β‐Cell Function in Response to Glucose Loading in Individuals with Non‐Insulin‐Dependent Diabetes MellitusThe Journal of Clinical Pharmacology, 2001